NEW YORK, NY — As Breast Cancer Awareness Month unfolds across the globe, the familiar sea of pink ribbons often focuses on early detection, mammograms, and survivorship. However, for a significant portion of the population, the narrative is starkly different. Metastatic breast cancer (MBC)—Stage 4 cancer that has spread beyond the breast to distant organs such as the bones, liver, lungs, or brain—remains a terminal diagnosis.
On October 13, National Metastatic Breast Cancer Awareness Day, the nonprofit organization METAvivor is set to reclaim the spotlight with a global phenomenon: #LightUpMBC. By illuminating more than 325 landmarks in the signature colors of teal, green, and pink, the campaign seeks to shift the public consciousness from mere awareness to aggressive, research-backed action.
The Reality of Stage 4: Defining the "Invisible" Crisis
To understand the urgency of the #LightUpMBC campaign, one must first confront the medical reality of metastatic breast cancer. Unlike early-stage breast cancer, which may be treated with the intent of a cure, MBC is characterized by the migration of cancer cells to vital organs.
Even when the cancer originates in the breast, once it metastasizes, it retains its identity as breast cancer, requiring specialized systemic treatment. For many patients, the diagnosis is a lifelong journey of "living with cancer." While medical advancements have allowed some patients to live for years—and in some cases, over a decade—with the disease, it remains a chronic, unpredictable condition.
Patients often face a "revolving door" of treatments. As cancer cells evolve and become resistant to therapies, patients must pivot to new, often more toxic, protocols. The goal is no longer eradication, but rather the preservation of life and the maintenance of quality of life. The sobering reality is that an estimated 42,670 people in the United States are projected to die from breast cancer in 2026 alone—a figure that equates to approximately 117 lives lost every single day. This statistic underscores the desperate, immediate need for research into novel therapies that can turn a terminal diagnosis into a manageable, long-term condition.
A Chronology of Advocacy: From a Single Light to a Global Beacon
The journey of #LightUpMBC is rooted in personal loss and the desire for systemic change. The campaign’s origins can be traced back to a promise made between friends.
- 2017: The movement began with a single act of remembrance. The Memorial Bridge in Portsmouth, New Hampshire, became the first landmark to be illuminated in teal, green, and pink, honoring those who had succumbed to MBC. This pilot effort was spearheaded by Laura Inahara, who was inspired by her best friend, Jessica Moore.
- The Vision: Moore, who passed away at the age of 36, harbored a simple hope: to see at least one local landmark light up for the cause. Her vision, however, far outpaced her initial expectations.
- 2018–2025: The campaign grew exponentially, moving from local bridges to iconic international landmarks. Through social media advocacy and community-driven outreach, the movement expanded across the United States, then into Canada, Europe, and Asia.
- October 13, 2026: This year marks the most expansive iteration of the campaign to date. Over 325 landmarks—ranging from the One World Trade Center in New York and the Willis Tower in Chicago to the historic Ness Bridge in Scotland and the Mactan-Cebu Airport in the Philippines—will stand as beacons of hope.
This chronology illustrates a shift in how patient advocacy groups operate. By leveraging visual spectacle to drive digital engagement, #LightUpMBC has successfully raised over $2.7 million for research, proving that personal grief can be transformed into a powerful catalyst for scientific progress.
Supporting Data: Why Research Funding is the Only Path Forward
The core mission of METAvivor, the engine behind #LightUpMBC, is to fund research exclusively for Stage 4 metastatic breast cancer. In the medical research ecosystem, metastatic research has historically been underfunded compared to early-stage screening and prevention. METAvivor addresses this disparity through a highly competitive and transparent process.
The Scientific Review Process
METAvivor employs a two-tier review system:
- Scientific Peer Review: Independent experts evaluate the technical feasibility and innovation of research proposals.
- Patient Advocate Review: This unique step ensures that the proposed research is not just scientifically sound but also clinically relevant to the daily lives of patients. Advocates evaluate how the research might impact quality of life, symptom management, and long-term survival.
By ensuring that 100% of net proceeds from the #LightUpMBC campaign go directly toward these research grants, the organization effectively bridges the gap between laboratory discovery and patient application.
Official Responses and Voices of Experience
The leadership of METAvivor is comprised largely of individuals who live with the disease, grounding the organization’s high-level strategy in the lived experience of the patient community.
Dr. Kelly Shanahan, Board President of METAvivor, serves as a poignant example of the progress made possible by ongoing research. Diagnosed with MBC in 2013, she admits that the initial prognosis did not offer the luxury of a 13-year outlook.
"When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan remarked. "My hope and the hope of so many others lies in research, and METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research, and is also a way to bring us together as a community."
This sentiment is echoed by the campaign’s founder, Laura Inahara. For Inahara, the campaign is a living tribute. "Jessica hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love, teaches patients with MBC how to advocate for themselves, and has now raised over $2.7 million for critical MBC research."
LightUpMBC Live: Bridging the Gap Between Science and Storytelling
The focal point of the awareness day is the #LightUpMBC Live broadcast. Scheduled for October 13 at 8 p.m. ET (5 p.m. PT), the event is designed to be more than just a fundraiser; it is a platform for education and community building.
Program Highlights
The livestream will be hosted by Tami Eagle Bowling, an 11-year survivor of MBC, and Broadway star and breast cancer survivor Kara Lindsay. The program promises a unique blend of content:
- Patient Narratives: Live segments will be broadcast from various illuminated landmarks, allowing viewers to hear directly from those living with the disease.
- Scientific Insight: Experts will break down the current state of MBC research, offering clarity on what "living with cancer" means in the era of targeted therapies.
- Artistic Tributes: The broadcast will feature performances from renowned artists, including Tony Award winner Victoria Clark, Dorian Harewood, Christina Bianco, Cassandra Kubinski, and Tony Daniels.
The event will be accessible to a global audience, streaming for free on the METAvivor YouTube channel, Facebook Live, and the LiveOne platform.
Implications: Moving Beyond Awareness
The implications of the #LightUpMBC campaign are profound. By moving the conversation away from the "pink-washing" of early-stage awareness, the movement is successfully educating the public on the complexities of metastatic disease.
- Normalization of the Conversation: By creating a visual, global event, the campaign makes the "invisible" terminal patient population visible.
- Increased Funding Streams: The $2.7 million raised thus far is a testament to the power of collective micro-donations. It demonstrates that the public is eager to support research when they are given a clear, actionable way to contribute.
- Scientific Acceleration: Every dollar funneled into METAvivor’s research grants increases the likelihood of finding the "next breakthrough"—a treatment that could shift the paradigm of MBC from a terminal, palliative focus to a chronic, manageable, and potentially curable reality.
As the sun sets on October 13, the sight of hundreds of landmarks glowing in teal, green, and pink will serve as a powerful visual metaphor: even in the darkest of diagnoses, there is light to be found in collective action, scientific inquiry, and the unwavering resolve of a community that refuses to be ignored.
For those interested in participating, donating, or viewing the list of participating landmarks, please visit www.lightupmbc.org. The fight against metastatic breast cancer is not just a medical challenge—it is a global mandate.
About the Author
